1,089
Participants
Start Date
July 19, 2023
Primary Completion Date
October 26, 2029
Study Completion Date
September 26, 2030
Intismeran autogene
IM injection
Pembrolizumab
IV infusion
Placebo
IM injection
National Cheng Kung University Hospital-Clinical Trial Center ( Site 4004), Tainan City
Harbour Cancer & Wellness ( Site 1500), Auckland
UZ Brussel-Medische oncologie ( Site 3405), Brussels
Melanoma Institute Australia-Clinical Trials Unit ( Site 1000), Wollstonecraft
Westmead Hospital ( Site 1001), Westmead
Medical Oncology Centre of Rosebank ( Site 4106), Johannesburg
Herlev and Gentofte Hospital ( Site 3301), Copenhagen
Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 1005), Melbourne
UZ Leuven ( Site 3400), Leuven
Paula Fox Melanoma & Cancer Centre ( Site 1004), Melbourne
Ziekenhuis Oost-Limburg, Campus St.-Jan ( Site 3402), Genk
Princess Alexandra Hospital ( Site 1003), Brisbane
Odense Universitetshospital ( Site 3300), Odense C
One Clinical Research ( Site 1002), Nedlands
Capital, Coast and Hutt Valley District - Wellington Regional Hospital ( Site 1502), Newtown
Kantonsspital Graubünden-Medizin ( Site 1703), Chur
Cape Town Oncology Trials ( Site 4100), Cape Town
UniversitätsSpital Zürich-Dermatology ( Site 1700), Zürich Flughafen
AZ Groeninge Campus Kennedylaan-Oncology ( Site 3401), Kortrijk
UZ Gent ( Site 3403), Ghent
Aalborg Universitetshospital, Syd ( Site 3302), Aalborg
National Taiwan University Hospital ( Site 4001), Taipei
NYU Langone Health-Perlmutter Cancer Center ( Site 1917), New York
Columbia University Irving Medical Center-CUIMC Herbert Irving Comprehensive Cancer Center Clinical ( Site 1908), New York
Memorial Sloan Kettering Cancer Center ( Site 1914), New York
Charité Universitaetsmedizin Berlin - Campus Mitte-Hauttumorcentrum Charité (HTCC) ( Site 1302), Berlin
Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 1958), Mineola
Assistance Publique Hôpitaux de Marseille - Hôpital de la Ti-Service de Dermatologie et Cancérologi ( Site 1203), Marseille
UPMC Hillman Cancer Center ( Site 1909), Pittsburgh
Universitätsmedizin Rostock-Klinik und Poliklinik für Dermatologie und Venerologie ( Site 1310), Rostock
Hospital of the University of Pennsylvania Perelman Center for Advanced Medicine ( Site 1905), Philadelphia
Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 1401), Milan
Istituto Europeo di Oncologia IRCCS ( Site 1404), Milan
Universitaetsklinikum Hamburg-Eppendorf ( Site 1309), Hamburg
Centre Georges François Leclerc ( Site 1210), Dijon
Johns Hopkins Hospital-Sidney Kimmel Comprehensive Cancer Center - Melanoma ( Site 1912), Baltimore
Inova Schar Cancer Institute ( Site 1900), Fairfax
Skånes Universitetssjukhus Lund ( Site 3201), Lund
CHU Besançon ( Site 1209), Besançon
University of North Carolina Medical Center-Lineberger Comprehensive Cancer Center ( Site 1949), Chapel Hill
Duke Cancer Institute ( Site 1911), Durham
Hospital Universitario Ramón y Cajal ( Site 1602), Madrid
HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID ( Site 1603), Pozuelo de Alarcón
H.R.U Málaga - Hospital General-Oncology ( Site 1605), Málaga
Medical University of South Carolina-Hollings Cancer Center ( Site 1934), Charleston
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 1950), Marietta
Winship Cancer Institute of Emory University ( Site 1940), Atlanta
Johannes Wesling Klinikum Minden-Skin Cancer Center Minden ( Site 1301), Minden
Orlando Health Cancer Institute ( Site 1937), Orlando
CHU de Bordeaux Hop St ANDRE-Service de Dermatologie ( Site 1204), Bordeaux
Chang Gung Medical Foundation-Linkou Branch ( Site 4003), Taoyuan District
Moffitt Cancer Center, Richard M. Shulze Family Foundation Outpatient Center ( Site 1945), Tampa
Acibadem Universitesi Atakent Hastanesi-Medical Oncology ( Site 3008), Istanbul
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 3003), Istanbul
Chungnam national university hospital-Department of Internal Medicine ( Site 3903), Daejeon
Centre Eugène Marquis Rennes - Centre de Lutte Contre le Cancer ( Site 1206), Rennes
Ege University Medical Faculty Hospital ( Site 3011), Izmir
I.E.U. Medical Point Hastanesi-Oncology ( Site 3005), Izmir
Universitätsmedizin Göttingen - Georg-August-Universität-Dermatology ( Site 1308), Göttingen
SCRI Oncology Partners ( Site 1910), Nashville
Kyungpook National University Chilgok Hospital-Hematology/oncology ( Site 3904), Daegu
Universitaetsklinikum Essen-Klinik für Dermatologie, Venerologie und Allergologie ( Site 1300), Essen
HOSPITAL CLINICO DE VALENCIA ( Site 1604), Valencia
University of Michigan ( Site 1915), Ann Arbor
Cancer and Hematology Centers of Western Michigan ( Site 1932), Grand Rapids
Universitaetsklinikum Koeln ( Site 1307), Cologne
University of Iowa-Holden Comprehensive Cancer Center ( Site 1935), Iowa City
Azienda Ospedaliero Universitaria Senese-U.O.C. Immunoterapia Oncologica ( Site 1402), Siena
Sanford Cancer Center ( Site 1951), Sioux Falls
Hopital Claude Huriez - CHU de Lille ( Site 1207), Lille
Universitaetsklinikum des Saarlandes ( Site 1313), Homburg
Universitätsmedizin Mannheim ( Site 1305), Mannheim
centre hospitalier lyon sud-Service de dermatologie ( Site 1202), Pierre-Bénite
Highlands Oncology Group ( Site 1943), Springdale
Hôpital Saint-Louis ( Site 1200), Paris
Texas Oncology - Dallas (Sammons) ( Site 1902), Dallas
University of Texas MD Anderson Cancer Center ( Site 1920), Houston
Texas Oncology - Austin ( Site 1903), Austin
CHU d'Amiens-Picardie - Hôpital Sud-Dermatologie ( Site 1208), Amiens
Istituto Nazionale Tumori IRCCS Fondazione Pascale-s.c. melanoma, immunoterapia oncologica e terapi ( Site 1400), Napoli
Klinik und Poliklinik für Dermatologie und Allergologie-Dermato-oncology ( Site 1315), München
Chang Gung Memorial Hospital at Kaohsiung ( Site 4000), Kaohsiung City
Universitaetsklinikum Augsburg ( Site 1312), Augsburg
UCLA Hematology/Oncology - Westwood (Building 100) ( Site 1918), Los Angeles
UCSF Medical Center at Mission Bay ( Site 1929), San Francisco
Gustave Roussy-Dermatologie ( Site 1201), Villejuif
Fred Hutchinson Cancer Center ( Site 1901), Seattle
Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia-Center Investigator ( Site 2500), Bogotá
IMAT S.A.S ( Site 2503), Montería
Fundación Valle del Lili ( Site 2505), Santiago de Cali
Emek Medical Center ( Site 2003), Afula
Rabin Medical Center ( Site 2000), Petah Tikva
Sheba Medical Center ( Site 2001), Ramat Gan
FALP-UIDO ( Site 2400), Santiago
Clínica UC San Carlos de Apoquindo-Hemato-Oncology ( Site 2402), Santiago
Bradfordhill ( Site 2401), Santiago
Hadassah Medical Center ( Site 2004), Jerusalem
Yale-New Haven Hospital-Yale Cancer Center ( Site 1933), New Haven
Massachusetts General Hospital ( Site 1927), Boston
Beth Israel Deaconess Medical Center ( Site 1957), Boston
Dana-Farber Cancer Institute ( Site 1956), Boston
John Theurer Cancer Center at Hackensack University Medical Center ( Site 1944), Hackensack
Atlantic Health System ( Site 1925), Morristown
Valley Health Systems - Ridgewood Campus ( Site 1947), Ridgewood
Clinica Adventista Belgrano-Oncology ( Site 2204), Caba.
Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 2202), Ciudad Autonoma de Buenos Aires
Instituto Alexander Fleming-Alexander Fleming ( Site 2203), Buenos Aires
Centro Privado de RMI Río Cuarto S.A. II ( Site 2201), Río Cuarto
Hospital Aleman ( Site 2200), Buenos Aires
Sanatorio Finochietto ( Site 2205), Buenos Aires
Centro Avançado de Tratamento Oncológico- CENANTRON ( Site 2303), Belo Horizonte
ONCOSITE - Centro de Pesquisa Clinica em Oncologia ( Site 2302), Ijuí
Hospital Nossa Senhora da Conceição ( Site 2309), Porto Alegre
Instituto Nacional de Câncer - INCA-Pesquisa Clinica HC II ( Site 2305), Rio de Janeiro
ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO ( Site 2300), São Paulo
Cross Cancer Institute ( Site 1104), Edmonton
BC Cancer Vancouver-Clinical Trials Unit ( Site 1106), Vancouver
William Osler Health System ( Site 1105), Brampton
Sunnybrook Research Institute ( Site 1103), Toronto
Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 1102), Toronto
Centre Hospitalier de l'Université de Montréal-Unité de Recherche Clinique en Oncologie et Hématolo ( Site 1100), Montreal
Centre intégré de cancérologie du CHU de Québec Université L-Hemato-Oncology ( Site 1101), Québec
Clinica Somer-Unidad de Investigacion y Docencia ( Site 2506), Rionegro
Centre Hospitalier Universitaire de Nice - Hôpital l'Archet-Dermatology Department ( Site 1211), Nice
SRH Wald-Klinikum Gera-Zentrum für klinische Studien ( Site 1306), Gera
"General Hospital of Athens Laiko-First Department of Internal Medicine ( Site 3700)", Athens
Metropolitan Hospital-A' Oncology Dpt ( Site 3701), Neo Faliro
Bioclinic Thessalonikis Private Clinic Single Member S.A.-Oncology ( Site 3703), Thessaloniki
European Interbalkan Medical Center-Oncology Department ( Site 3702), Thessaloniki
AO Santa Maria della Misericordia ( Site 1403), Perugia
Nagoya University Hospital ( Site 4201), Nagoya
Shizuoka Cancer Center ( Site 4202), Nagaizumi-cho,Sunto-gun
National Cancer Center Hospital ( Site 4200), Chūō
Uniwersytecki Szpital Kliniczny w Poznaniu ( Site 2909), Poznan
Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 2908), Bydgoszcz
Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 2903), Siedlce
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie ( Site 2900), Warsaw
Bialostockie Centrum Onkologii ( Site 2905), Bialystok
Uniwersyteckie Centrum Kliniczne-Klinika Chirurgii Onkologicznej, Transplantacyjnej i Ogólnej ( Site 2906), Gdansk
Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 2907), Gliwice
Zachodniopomorskie Centrum Onkologii ( Site 2904), Szczecin
Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakl-Klinika Onkologii Klinicznej, Dzial Ch ( Site 2902), Kielce
Instituto Português de Oncologia de Lisboa Francisco Gentil ( Site 3601), Lisbon
Unidade Local de Saude Lisboa Ocidental - Hospital de São Francisco Xavier ( Site 3602), Lisbon
Unidade Local de Saude de Santa Maria - Hospital de Santa Maria ( Site 3603), Lisbon
Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 3604), Porto
Wilgers Oncology Centre ( Site 4103), Pretoria
Seoul National University Hospital-Oncology ( Site 3902), Seoul
Severance Hospital, Yonsei University Health System-Medical oncology ( Site 3901), Seoul
Samsung Medical Center-Division of Hematology/Oncology ( Site 3900), Seoul
HOSPITAL CLÍNIC DE BARCELONA-ICHMO- Clinic Institut of Haematological and Oncological diseases ( Site 1600), Barcelona
Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 1601), Barcelona
Sahlgrenska Universitetssjukhuset ( Site 3200), Gothenburg
Hacettepe Universite Hastaneleri ( Site 3006), Ankara
Memorial Ankara Hastanesi-Medical Oncology ( Site 3010), Ankara
Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 3002), Ankara
Bristol Haematology and Oncology Centre ( Site 1811), Bristol
Addenbrooke's Hospital ( Site 1800), Cambridge
Norfolk and Norwich University Hospitals NHS Foundation Trust ( Site 1813), Cringleford
University College London Hospital ( Site 1807), London
ROYAL MARSDEN HOSPITAL (CHELSEA) ( Site 1804), London
Western General Hospital ( Site 1806), Edinburgh
The Churchill Hospital ( Site 1805), Oxford
St James's University Hospital-Leeds Cancer Centre ( Site 1808), Leeds
The Christie NHS Foundation Trust ( Site 1814), Manchester
ModernaTX, Inc.
INDUSTRY
Merck Sharp & Dohme LLC
INDUSTRY